Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #169347 on Biotech Values
oc631
11/05/13 8:36 AM
#169351 RE: genisi #169347
And if you were a GT1 treatment-naïve patient, would you take ABBV's regimen or GILD's (assuming 12 weeks treatment and SVRs are in the same ballpark)?